Table 3 Cytotoxicity of compounds 15, 16, 17, 18, 19, 20 and Doxorubicin against hepatocellular carcinoma cell line HePG2

500

6.49

4.31

6.78

4.68

3.84

6.91

3.6

250

11.25

11.72

15.93

10.35

9.65

11.76

3.97

125

19.43

18.25

24.85

17.46

13.81

20.95

6.43

62.5

30.61

23.87

34.91

25.72

19.46

32.47

9.68

31.25

39.45

30.64

42.87

32.69

25.83

44.35

16.45

15.6

51.26

38.92

67.29

44.82

32.17

76.97

23.87

7.8

67.18

47.30

83.97

51.96

39.68

89.50

30.69

3.9

84.91

64.59

91.48

64.53

48.54

94.16

37.54

2

92.73

76.28

98.02

72.31

61.83

98.73

42.91

1

96.48

81.49

100

79.48

69.42

100

48.76

0

100

100

100

100

100

100

100